Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ABBOTT LABORATORIES T.ABT


Primary Symbol: ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.


NYSE:ABT - Post by User

Post by Betteryear2on Apr 07, 2022 9:28am
186 Views
Post# 34583732

Unveils Advances in Resilient Zero Trust Security TSX: ABST

Unveils Advances in Resilient Zero Trust Security TSX: ABST

VANCOUVER, British Columbia & SAN JOSE, Calif.--()--Absolute Software™ (NASDAQ: ABST) (TSX: ABST), a leader in self-healing endpoint and secure access solutions, today announced enhancements to its Secure Access product portfolio (formerly NetMotion by Absolute), enabling customers to minimize risk exposure and further optimize the user experience in today’s borderless, work-from-anywhere environments. With this release, Absolute is delivering a broad range of new product innovations including self-healing Zero Trust Network Access (ZTNA); a resilient deployment architecture, and expanded network and ZTNA policy intelligence.

 

https://www.businesswire.com/news/home/20220407005358/en/

 

<< Previous
Bullboard Posts
Next >>